Showing results (251-260 of 495) with videos related to

Sort By:
Pageof 50
Gynecologic Oncology|March 30, 1999
The accuracy of frozen-section diagnosis in metastatic breast and colorectal carcinoma to the adnexaN R Abu-Rustum, D S Chi, B A Wiatrowska, et al.
Obstetrics and Gynecology|November 1, 1993
Second-look laparotomy in carcinoma of the fallopian tubeR R Barakat, S C Rubin, P E Saigo, et al.
Obstetrics and Gynecology|July 1, 1993
Second-look laparotomy in stage I ovarian cancer following comprehensive surgical stagingS C Rubin, W B Jones, J P Curtin, et al.
Gynecologic Oncology|August 2, 2003
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinomaMary L Gemignani, Alan C Schlaerth, Faina Bogomolniy, et al.
Radiology|January 8, 2011
The value of MR imaging when the site of uterine cancer origin is uncertainHebert Alberto Vargas, Oguz Akin, Junting Zheng, et al.
Gynecologic Oncology|February 28, 2012
Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosisMario M Leitao, Oliver Zivanovic, Dennis S Chi, et al.
Gynecologic Oncology|August 2, 2003
The effects of CO2 pneumoperitoneum on the survival of women with persistent metastatic ovarian cancerNadeem R Abu-Rustum, Yukio Sonoda, Dennis S Chi, et al.
Gynecologic Oncology|May 8, 1998
A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessmentR R Barakat, L Almadrones, E S Venkatraman, et al.
European Radiology|December 25, 2012
Peritoneal inclusion cysts: clinical characteristics and imaging featuresWouter B Veldhuis, Oguz Akin, Debra Goldman, et al.
Gynecologic Oncology|May 31, 2014
Quantifying the risk of recurrence and death in stage III (FIGO 2009) endometrial cancerSarah A Milgrom, Marisa A Kollmeier, Nadeem R Abu-Rustum, et al.
Pageof 50